This trial will collect tissue oxygenation data via hyperspectral imaging before and after endovascular procedures.
This will be a nonrandomized, nonblinded, prospective observational study to correlate the results obtained with the traditional measures of success of endovascular revascularization of peripheral arteries for the treatment of chronic limb ischemia; i.e., ABPI, PVR with oxyhemoglobin (OxyHb) and deoxyhemoglobin (DeoxyHb) measurements obtained with a new imaging device manufactured by HyperMed Inc (OxyVu) that uses hyperspectral technology.
Study Type
OBSERVATIONAL
Enrollment
60
Cardiac, Vascular & Thoracic Surgery Associates
Falls Church, Virginia, United States
RECRUITINGThis platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.